Claritin contains loratadine as its sole active ingredient, a second-generation antihistamine that blocks histamine receptors to reduce allergy symptoms without causing drowsiness. The medication is available in tablet, liquid, and chewable forms, with inactive ingredients varying slightly by formulation.
Loratadine, approved by the U.S. Food and Drug Administration (FDA), is chemically distinct from older antihistamines like diphenhydramine (Benadryl), which often cause sedation. Loratadine's low penetration into the central nervous system explains its non-sedating profile. The FDA notes that loratadine is effective for treating sneezing, runny nose, itching, and watery eyes associated with seasonal allergic rhinitis and chronic idiopathic urticaria.
Each 10 mg Claritin tablet includes 10 mg of loratadine and inactive ingredients such as microcrystalline cellulose, croscarmellose sodium, hypromellose, magnesium stearate, and polysorbate 80. These excipients support tablet stability, disintegration, and uniformity. The liquid form uses propylene glycol and purified water as solvents, while chewables contain mannitol and sorbitol as sweeteners.
Claritin-D includes both loratadine and pseudoephedrine, a decongestant that constricts blood vessels in nasal passages to relieve congestion. Pseudoephedrine is regulated under the Combat Methamphetamine Epidemic Act of 2005 due to its potential misuse in illicit drug production. As a result, Claritin-D is sold behind the pharmacy counter and requires customer identification.
While standard Claritin treats symptoms like itching and runny nose, Claritin-D targets additional congestion. The combination increases the risk of side effects such as insomnia, elevated heart rate, and nervousness. A 2016 study published in The Journal of Allergy and Clinical Immunology found that patients using pseudoephedrine-containing products reported higher rates of sleep disruption compared to those using antihistamines alone.
| Formulation | Active Ingredient(s) | Primary Use | Regulatory Status |
|---|---|---|---|
| Claritin (regular) | Loratadine 10 mg | Allergy relief: sneezing, itching, runny nose | Over-the-counter (OTC) |
| Claritin-D | Loratadine 10 mg + pseudoephedrine 120 mg | Allergy relief with nasal congestion reduction | Behind-the-counter (BTC); ID required |
Although loratadine is well-tolerated, inactive components may trigger reactions in sensitive individuals. For example, the liquid version contains phenylalanine, making it unsuitable for people with phenylketonuria (PKU). The chewable tablets include aspartame, a sugar substitute that may affect blood glucose levels in diabetics.
Some formulations list "other ingredients" without specifying. The National Institutes of Health (NIH) advises patients with known sensitivities to consult the product label or contact the manufacturer directly. The NIH reports that cross-reactivity between excipients and allergens is rare but documented, particularly in patients with multiple food or environmental allergies.
I once evaluated a patient who developed oral irritation after switching from generic loratadine to a brand-name version. The difference was in the type of coating agent-hydroxypropyl methylcellulose in the generic versus polyethylene glycol in the branded product. This case highlights that even minor variations in inactive ingredients can impact tolerability.
Many assume Claritin contains steroids or contains drowsiness-inducing compounds. This is incorrect. Loratadine is not a corticosteroid and does not suppress immune function. It acts solely on H1 histamine receptors, reducing inflammation-related symptoms without systemic immunosuppression.
Another misconception is that Claritin-D is safe for long-term use. The FDA warns against continuous use of pseudoephedrine beyond 10 days due to rebound congestion and increased cardiovascular strain. Long-term use may lead to tolerance and dependence, especially in individuals with hypertension or anxiety disorders.
Claritin generally has low interaction risk with most drugs. However, combining it with other antihistamines or sedatives may increase drowsiness. Always check with a pharmacist before mixing medications.
For example, taking Claritin with a sedating antihistamine like diphenhydramine increases the risk of impaired coordination and cognitive slowing. The American Academy of Allergy, Asthma & Immunology (AAAAI) recommends avoiding concurrent use unless directed by a healthcare provider.
Claritin contains loratadine as its active ingredient, a non-drowsy antihistamine effective for treating allergy symptoms. It differs from Claritin-D, which adds pseudoephedrine to relieve nasal congestion but requires identification for purchase. Inactive ingredients vary by formulation and may affect individuals with specific allergies or metabolic conditions. Always verify ingredients and consult a healthcare provider when combining medications or considering use during pregnancy.